Literature DB >> 28755984

Penehyclidine hydrochloride preconditioning provides cardiac protection in a rat model of myocardial ischemia/reperfusion injury via the mechanism of mitochondrial dynamics mechanism.

Yanli Yang1, Liyun Zhao2, Jun Ma3.   

Abstract

To investigate that penehyclidine hydrochloride (PHC) plays a cardiac protection role in myocardial ischemia/reperfusion injury (IRI) through mitochondrial dynamics mechanism. Rat model of myocardial I/R injury was established by the ligation of left anterior descending coronary artery for 30min followed by 3h perfusion. Before I/R, the rats were pretreated with or without PHC. Cardiac function was measured by echocardiography. The activities/levels of myocardial enzymes, oxidants and antioxidant enzymes were detected. Evans blue/TTC double staining was performed to assess infarct size. Cell apoptosis was evaluated by TUNEL assay. Western blot and real time fluorescent quantitative PCR was performed to analyze the expression of Drp1, Mfn1, Mfn2. Meanwhile, the rats were given a single injection of PHC before I/R. The effects of PHC on myocardial infarct and cardiac function were investigated after 7 days post-reperfusion. Our results showed that PHC pretreatment improved imbalance of mitochondrial dynamics induced by oxidative stressor in IRI. PHC preconditioning alleviated apoptotic rate of cell by improving the imbalance of mitochondrial dynamics in IRI. Meanwhile, we showed that PHC remarkably improved cardiac function, myocardial injury by decreasing infarct size and attenuated levels of myocardial enzyme. Additionally, PHC also exerted long-term cardiac protection in a rat model of I/R injury by decreasing infarct size and improving cardiac function. These results suggested that PHC could efficiently protect the rats against I/R-induced myocardial injury via the mechanism of mitochondrial dynamics.
Copyright © 2017. Published by Elsevier B.V.

Entities:  

Keywords:  Ischemia/reperfusion injury; Mitochondrial dynamics; Penehyclidine hydrochloride

Mesh:

Substances:

Year:  2017        PMID: 28755984     DOI: 10.1016/j.ejphar.2017.07.031

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Current Understanding of the Pivotal Role of Mitochondrial Dynamics in Cardiovascular Diseases and Senescence.

Authors:  Yoshihiro Uchikado; Yoshiyuki Ikeda; Mitsuru Ohishi
Journal:  Front Cardiovasc Med       Date:  2022-05-18

Review 2.  Pleiotropic effects and pharmacological properties of penehyclidine hydrochloride.

Authors:  Yaguang Wang; Yafen Gao; Jun Ma
Journal:  Drug Des Devel Ther       Date:  2018-10-05       Impact factor: 4.162

3.  Vitamin D Attenuates Ischemia/Reperfusion-Induced Cardiac Injury by Reducing Mitochondrial Fission and Mitophagy.

Authors:  Tzu-Lin Lee; Ming-Hsueh Lee; Yu-Chen Chen; Yi-Chieh Lee; Tsai-Chun Lai; Hugo You-Hsien Lin; Lee-Fen Hsu; Hsin-Ching Sung; Chiang-Wen Lee; Yuh-Lien Chen
Journal:  Front Pharmacol       Date:  2020-12-10       Impact factor: 5.810

4.  Analyses of changes in myocardial long non-coding RNA and mRNA profiles after severe hemorrhagic shock and resuscitation via RNA sequencing in a rat model.

Authors:  Lin Lin; Zhengfei Yang; Guanghui Zheng; Yongxun Zhuansun; Yue Wang; Jianguo Li; Rui Chen; Wanchun Tang
Journal:  BMC Mol Biol       Date:  2018-11-01       Impact factor: 2.946

5.  Gastrodin protects H9c2 cardiomyocytes against oxidative injury by ameliorating imbalanced mitochondrial dynamics and mitochondrial dysfunction.

Authors:  Qiao-Qiao Cheng; Yu-Wei Wan; Wei-Min Yang; Meng-Hua Tian; Yu-Chuan Wang; Hai-Yan He; Wei-Dong Zhang; Xuan Liu
Journal:  Acta Pharmacol Sin       Date:  2020-03-12       Impact factor: 6.150

6.  Vitexin Mitigates Myocardial Ischemia/Reperfusion Injury in Rats by Regulating Mitochondrial Dysfunction via Epac1-Rap1 Signaling.

Authors:  Huanhua Yang; Wei Xue; Caijuan Ding; Cheng Wang; Bohan Xu; Shuo Chen; Binshan Zha; Yuqian Sun; Huaqin Zhu; Junyan Zhang; Liuyi Dong
Journal:  Oxid Med Cell Longev       Date:  2021-06-28       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.